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Abstract
Thioacetamide (TA) is a well-known hepatotoxin in rats. Acute doses cause centrilobular necrosis
and hyperbilirubinemia while chronic administration leads to biliary hyperplasia and
cholangiocarcinoma. Its acute toxicity requires its oxidation to a stable S-oxide (TASO) that is
oxidized further to a highly reactive S,S-dioxide (TASO2). To explore possible parallels between
the metabolism, covalent binding and toxicity of TA and thiobenzamide (TB) we exposed freshly
isolated rat hepatocytes to [14C]-TASO or [13C2D3]-TASO. TLC analysis of the cellular lipids
showed a single major spot of radioactivity that mass spectral analysis showed to consist of N-
acetimidoyl PE lipids having the same side chain composition as the PE fraction from untreated
cells; no carbons or hydrogens from TASO were incorporated into the fatty acyl chains. Many
cellular proteins contained N-acetyl- or N-acetimidoyl lysine residues in a 3:1 ratio (details to be
reported separately). We also oxidized TASO with hydrogen peroxide in the presence of
dipalmitoyl phosphatidylenthanolamine (DPPE) or lysozyme. Lysozyme was covalently modified
at five of its six lysine side chains; only acetamide-type adducts were formed. DPPE in liposomes
also gave only amide-type adducts, even when the reaction was carried out in tetrahydrofuran with
only 10% water added. The exclusive formation of N-acetimidoyl PE in hepatocytes means that
the concentration or activity of water must be extremely low in the region where TASO2 is
formed, whereas at least some of the TASO2 can hydrolyze to acetylsulfinic acid before it reacts
with cellular proteins. The requirement for two sequential oxidations to produce a reactive
metabolite is unusual, but it is even more unusual that a reactive metabolite would react with water
to form a new compound that retains a high degree of chemical reactivity toward biological
nucleophiles. The possible contribution of lipid modification to the hepatotoxicity of TA/TASO
remains to be determined.
Introduction
Compounds that possess a thiocarbonyl group (>C=S) have been found to serve a wide
range of roles in medicine, agriculture and industry. Most of these compounds fall into one
of three broad structural classes: thioamides, thioureas, and thiosemicarbazones. For
example, quazepam (1) is used as a hypnotic agent for insomnia while methimazole (2) is
used to treat hyperthyroidism. Other examples include the antitubercular agents ethionamide
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(3) and thiacetazone (4), the pneumotoxic rodenticide alpha-naphthylthiourea (5), and the
herbicide Prefix (6). Tolrestat (7) was developed as an aldose reductase inhibitor for
glaucoma but was withdrawn because of liver toxicity. 1,3-Diphenylthiourea (8) is used in
the production of synthetic rubber and is often responsible for hypersenitivity reactions to
rubber products. 1 Thiosemicarbazone derivatives related to 4 continue to attract attention as
promising anti-cancer agents. Nearly all thiocarbonyl compounds are metabolized at least in
part, and sometimes almost exclusively, by a general pathway known as oxidative
desulfurization.2
As noted below, intermediates in this pathway are often highly reactive and prone to react
covalently with cellular proteins. In many cases this leads to cytotoxicity and/or
immunological sensitization. Two thiocarbonyl compounds are of particular note in this
context: thiobenzamide (TB1, 9a) and thioacetamide (TA, 9b), both of which are widely
used to model hepatotoxicity and to investigate the connection between biotransformation
and toxicity.3–10 The metabolic activation of thiobenzamide is known to require two
sequential S-oxidations.11 The first produces an isolable S-oxide or “sulfine” metabolite
(TBSO, 10a), while the second produces a highly reactive S,S-dioxide or “sulfene”
metabolite (TBSO2, 11a) that tautomerizes to benzimidoylsulfinic acid (12a) as shown in
Scheme 2. The latter is capable of benzimidoylating cellular nitrogen nucleophiles including
protein lysine side chains 12 and PE lipids 13. TBSO2 can also undergo base-catalyzed
elimination of its sulfur group (via tautomer 12a) to form benzonitrile (13a) or react with
water to form benzamide (14a), both of which are stable metabolites. On the other hand
TBSO2 can also react with water to form benzoylsulfinic acid (15a) which can then react
further to benzoylate protein lysine side chains as in structure 16a. Finally, TBSO2 can react
directly with protein lysine side chains or with the amine group of
phosphatidylethanolamine (PE) lipids to form the corresponding benzimidoyl or amidino
adducts (17a or 18a, respectively). Interestingly, metabolism of TB does not lead to the
formation of N-benzoyl-PE lipids.13 Thioacetamide is also known to undergo metabolic
activation and covalent binding to protein lysine side chains via intermediates 10b, 11b, and
12b, 14, 15 so it might also be expected to modify PE lipids via N-acetylation or N-
acetimidoylation. A number of different N-acyl- PE lipid derivatives are known to form
endogenously,16–19 but N-imidoylated-PE species such as 18 are apparently not naturally
occurring.
The work described in this paper had two primary objectives. One was to determine whether
TA metabolism also leads to covalent modification of PE lipids in rat hepatocytes, and if so
to quantitate and characterize the nature of the modification(s). The second was to
characterize mass spectrometrically the adducts formed in vitro between TASO2 and a
model protein as a prelude to analyzing proteins adducted in vivo by thioacetamide
metabolites. Here we report that incubation of rat hepatocytes with [14C]-TASO, and
separately with a mixture of TASO and [13C2D3]-TASO, leads to substantial covalent
labeling of both cellular lipids and cellular proteins. Mass spectral analysis shows that the
lipid adducts are exclusively N-acetimidoylated PE lipids; N-acetyl-PE lipids are not
formed, nor are they detectable in untreated cells. In contrast, when generated in solution
from TASO and hydrogen peroxide, TASO2 reacts with PE to give N-acetyl-PE but not N-
acetimidoyl PE, and it reacts with the model protein lysozyme forming acetyl but not
acetimidoyl adducts on protein-NH2 groups. Although it is not clear whether lipid
1Abbreviations: AGC, automatic gain control; CID, collision induced dissociation; DPPE, dipalmitoyl phosphatidylethanolamine;
ESI, electrospray ionization; MA, methyl acetimidate; NL, neutral loss; PC, phosphatidyl choline; PE, phosphatidylethanolamine; PI,
phosphatidyl inositol; PS, phosphatidyl serine; TA, thioacetamide; TASO, thioacetamide S-oxide; TASO2, thioacetamide S,S-
dsioxide; TB, thiobenzamide; TBSO, thiobenzamide S-oxide; TBSO2, thiobenzamie S,S-dioxide; THF, tetrahydrofuran; TLC, thin
layer chromatography.
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modification by TASO2 contributes to the toxicity of TA and TASO, it is clear that its
chemistry inside the hepatocyte is very different from its chemistry in simple aqueous
solution.
Experimental Procedures
1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPE) was obtained from Avanti
Polar Lipids, Inc. (Alabaster, AL). 14C-TASO and 13CD3 13C(SO)NH2 were synthesized
according to a literature procedure 20. All other chemicals and solvents were obtained from
Sigma Aldrich (St. Louis, MO). 1H and 13C NMR spectra were recorded on Bruker AV III
500 MHz spectrometer and spectra were referenced to the residual NMR solvent peak.
Column chromatography was performed using silica gel. Thin-layer chromatography was
performed either on Whatman LK5DF plates (www.whatman.com) or on Silica Gel GF
plates (2.5 × 10 cm, 0.25 mm, Analtech, www.ichromatography.com) with fluorescence
detection under UV light at 254 nm. The solvent system used for TLC was CHCl3/MeOH/
NH4OH (80/20/3). Lipids were visualized using iodine vapors or by spraying the plate with
10% CuSO4 solution in 10% H3PO4 followed by heating. Radioactivity on the TLC plate
was detected by exposing it to a Molecular Dynamics phosphor screen (3 days at room
temperature) and scanning the screen with a Typhoon Molecular Imager scanning unit
(GMI, Inc.; www.gmi-inc.com).
N-Acetyl-DPPE (19)
A mixture of acetic anhydride (3 mg, 0.030 mmol), DPPE (20 mg, 0.030 mmol) and
triethylamine (6 mg, 0.060 mmol) in chloroform was stirred at room temperature overnight.
The reaction mixture was diluted with ethyl acetate, washed with brine and the organic
portion was dried over anhydrous Na2SO4. The solvent was removed under vacuum and the
residue was purified by column chromatography over silica gel starting with 10% MeOH in
chloroform. Compound 19 (Scheme 3) was eluted using 50% MeOH in chloroform. TLC Rf
0.48 (80:20:3 CHCl3/MeOH/NH4OH). ESIMS: [M-H]− = 732.5153 ± .0022 (n=5); calcd
732.5185.
N-Acetimidoyl-DPPE (20)
Methyl acetimidate (MA) hydrochloride (0.003 g, 0.030 mmol), DPPE (0.020 g, 0.030
mmol) and triethylamine (0.006 g, 0.060 mmol) were combined in ethanol and heated to
reflux for 2 h. After cooling to room temperature, ethyl acetate was added and the mixture
was washed with brine solution. After drying the organic portion over anhydrous Na2SO4,
the solvent was removed under vacuum and the residue was purified by column
chromatography over silica gel starting with 10% MeOH in chloroform. Compound 20 was
eluted using 50% MeOH in chloroform. TLC Rf 0.37 (80:20:3 CHCl3/MeOH/NH4OH).
ESIMS: [M-H]− = 731.5329 ± .0036 (n=7); calcd 731.5345.
In vitro reactions of TASO/H2O2 with DPPE
A solution of DPPE (5 mg) in chloroform (3 mL) was dried to a film using a rotary
evaporator. Water (1 mL) was added and the flask was intermittently swirled vigorously
over 60 min while heating at 70 °C with a water bath. A solution of TASO (varying mole
ratio to DPPE) in 20 μL water was added directly to the resultant milky suspension of
micelles and liposomes (at either 70 °C or after cooling to room temperature), followed
immediately by 10 μL of an aqueous solution of H2O2 (titrated to contain slighly less than
one equivalent compared to TASO), and the mixture was stirred for 16 hours at room
temperature. An aliquot was then taken for direct analysis by LC/MS.
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In vitro reactions of hen egg lysozyme with acylating reagents
Reactions of hen egg lysozyme with TASO/H2O2 or methyl acetimidate or acetic anhydride
were conducted as follows. To a solution of lysozyme (10 mg) in water (1 mL) was added
130 μL of a solution of TASO in water (10 mg/mL) followed by addition of 26 μL of a
0.05% solution of aqueous hydrogen peroxide. Methyl acetimidate hydrochloride (8 mg)
was dissolved in water (400 μL), 7 mg of triethylamine was added via syringe, and a 15 μL
aliquot of this solution was added immediately to a solution of lysozyme (5 mg) in water (1
mL). Acetic anhydride (17 μL) was added directly to a solution of lysozyme (10 mg) in
water (1 mL). After standing at room temperature for at least 2 h all three solutions were
analyzed by whole-molecule ESIMS using direct flow injection through a C4 reverse-phase
desalting column. For peptide analysis aliquots were reduced with dithiothreitol and
alkylated with iodoacetamide in 0.1% SDS aqueous solution, precipitated with cold ethanol
at −20 °C overnight and digested with trypsin in 0.2 M ammonium bicarbonate at 37°C.21
In vitro reactions of TASO/H2O2 with DPPE and hen egg lysozyme
A solution of DPPE (5 mg) in chloroform (3 mL) was dried to a film using a rotary
evaporator. Water (1 mL) was added and the flask was intermittently swirled vigorously
over 60 min while heating at 70 °C with a water bath. A solution of TASO (varying mole
ratio to DPPE) in 20 μL water was added directly to the resultant milky suspension of
micelles and liposomes (at either 70 °C or after cooling to room temperature), followed
immediately by 10 μL of an aqueous solution of H2O2 (titrated to contain slighly less than
one equivalent compared to TASO), and the mixture was stirred for 16 hours at room
temperature. An aliquot was then taken for direct analysis by LC/MS. Reactions of hen egg
lysozyme (5 mg in 1 mL water) with TASO/H2O2 or methyl acetimidate or acetic anhydride
were conducted similarly at room temperature. After stirring for 2 hr the solutions were
analyzed directly by whole-molecule mass spectrometry. Aliquots were also reduced with
dithiothreitol, alkylated with iodoacetamide in a 0.1% SDS aqueous solution, precipitated
with cold ethanol at −20 °C overnight and digested with trypsin in 0.2M ammonium
bicarbonate at 37°C.
Preparation and Incubation of Isolated Hepatocytes
Male Sprague-Dawley rats from Charles River Laboratories were housed in a temperature
and humidity controlled room with a 12 h light/dark cycle and ad libitum access to food and
water. All animal husbandry procedures were in accordance with the Guide for the Care and
Use of Laboratory Animals (NIH Publication, Volume 25, 1996,
http://grants1.nih.gov/grants/guide/notice-files/not96-208.html). Experimental procedures
were approved by the Institutional Animal Care and Use Committee of the University of
Kansas. Hepatocytes from non-induced male Sprague-Dawley rats (175–275 g) were
isolated using a previously described protocol 22. After isolation the cells were transferred
to incubation medium (Williams’ medium E supplemented with 1% (v/v) Pen-Strep, 1% (v/
v) ITS (Insulin-Transferrin-Selenium), 100 nM dexamethasone, and 2 mM L-glutamine (all
from Gibco-Invitrogen, www.invitrogen.com).
For metabolism studies TASO (10 mM, 0.57 Ci/mol) was incubated with 2.2 × 107 freshly
isolated rat hepatocytes (>90% viability) suspended in the same medium (2.2 mL) in 50 mL
round bottom screw-cap culture tubes. Before adding the hepatocytes to the tubes the
required amounts of TASO were deposited by evaporation from a methanol solution.
Incubations were shaken at 100 Hz at 37°C under an atmosphere of O2/CO2 (95: 5) for 4 h.
For identification of lipid adducts, a mixture of [13C2D3]-TASO/TASO (10:6; total TASO,
10 mM) was substituted for radiolabeled TASO, and incubations were conducted identically.
The cells from duplicate 450 μL aliquots of incubations were pelleted by centrifugation and
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the pellets were subjected to Folch extraction23 using 19 volumes of MeOH/CHCl3 (2:1 v/
v).
Mass Spectrometry
Molecular weight confirmations of 19 and 20 were obtained from spectra acquired by
electrospray ionization on a LCT Premier (Waters Corp., Milford MA) time of flight mass
spectrometer. Mass scale correction for exact mass determinations were made with the lock
mass feature in the MassLynx data system using a reference compound presented with an
auxiliary sprayer. Collision induced dissociation (CID) spectra of standards (Figure 2) were
acquired using ESI on a Q-Tof-2 instrument (Micromass Ltd., Manchester UK). Argon was
the collision gas and the collision energy was varied from 15–35eV to obtain a distribution
of fragments from low to high mass.
Lipid type, or “head group specific”, CID spectra by precursor or neutral loss scans were
acquired on a Quattro Ultima “triple” quadrupole tandem mass spectrometer (Micromass
Ltd., Manchester UK) using ESI. The resolution of quadrupoles 1 and 3 were tuned to 0.6 u
FWHH. The collision gas (Ar) density was set to attenuate the precursor by 20% (6e-4 mBar
on gauge in collision supply line), a density optimized for precursor scans. Samples were
dissolved in MeOH/CHCl3/300mM NH4OAc (665:300:35) and sprayed through a stainless
steel needle set at 2.8 kV. Ions were sampled through the cone set to 35 V. Lipid “head
group specific” tandem mass spectrometry scans in positive and negative modes for
profiling membrane lipids were pioneered by Brugger 24 using ESI on a triple quadrupole
type instrument. Since then this approach has been widely adopted for lipid content profiling
including rat liver25 and adapted to the detection of anticipated xenobiotic lipid
metabolites.13
Intact protein ESI spectra were acquired on a SYNAPT G2 hybrid quadrupole/ion mobility/
Tof mass spectrometer (Waters Corp., Milford, MA). The instrument was operated in a
sensitivity mode with all lenses optimized on the MH+ ion from the leuenkephalin. The
sample cone voltage was 30 eV. Argon was admitted to the trap cell that was operated at
4eV for maximum transmission. Spectra were acquired at 9091 Hz pusher frequency
covering the mass range from 100 to 3000 u and accumulating data for 1.5 seconds per
cycle. Time to mass calibration was made with NaI cluster ions acquired under the same
conditions. Mass spectra of [Glu1]-fibrinopeptide B were acquired in parallel scans and
doubly charged ions at m/z 785.8426 were used as a lock mass reference. Samples were
desalted on a reverse phase C4 column, 1cm, 1mm I.D. (Vydac, 300 Å pore size, 5 μm
particles packed by Micro-Tech Scientific) using a NanoAcquity chromatographic system
(Waters Corp.). The solvents were A (99.9% H2O, 0.1% formic acid) and B (99.9%
acetonitrile, 0.1% formic acid). A short gradient from 1 to 70% B in 4 minutes with a flow
rate of 20 μL/min was used. MassLynx software (Waters Corp., version 4.1) was used to
collect the data. Raw multiply charged protein mass spectra were converted into molecular
weight spectra using MaxEnt1 or Transform utility of MassLynx.
Digested protein samples were analyzed by LC-MS/MS using a NanoAcquity
chromatographic system (Waters Corp.) coupled to an LTQ-FT mass spectrometer
(ThermoFinnigan, Bremen, Germany). Peptides were separated on a reverse-phase C18
column, 15cm, 300μm I.D. (Thermo Acclaim PepMap300, 300 Å 5 μm). A gradient was
developed from 1 to 40% B in 50 minutes, ramped to 95% B in 4 minutes and held at 95%B
for 5 minutes at a flow rate of 10 μL/min with solvents A and B identical to those used for
intact protein MS analysis. The NanoAquity UPLC Console (Waters Corp., version 1.3) was
used to control the injections and gradients. Data-dependent acquisition method for the mass
spectrometer (configured version LTQ-FT 2.2) was set up using Xcalibur software
(ThermoElectron Corp., version 2.0). Full spectrum survey scans were acquired at a
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resolution of 50,000 with an Automatic Gain Control (AGC) target of 5×105. Five most
abundant ions were fragmented in the LTQ with AGC target of 2×103 or maximum ion time
of 300 ms.
Results
Synthesis and characterization of modified PE standards
The oxidative biotransformation of thioacetamide was expected to generate chemically
reactive metabolites potentially capable of N-acetylating and/or N-acetimidoylating PE
lipids (Scheme 2). To facilitate the search for these adducts we prepared both N-acetyl-
DPPE (19) and N-acetimidoyl- DPPE (20) as reference standards. On thin layer
chromatography (Figure 1) these materials behaved analogously to N-benzoyl- and N-
benzimidoyl-DPPE as described by Ji et al.13 The mass spectra of these compounds (Figures
2A and 2B) show that they fragment easily at the glycerol-phosphate bond (Figure 2). In the
case of the amidines the phosphate-containing fragment retains a majority of the charge, but
for the less-basic amides the charge is carried almost exclusively by the diacylglycerol
(DAG)-derived fragment. Thus, it is convenient to search for N-acetimidoyl-PE derivatives
using MS/MS combined with precursor-ion scanning for m/z 183 (corresponding to the
amidine-phosphate fragment shown in Figure 2A). In contrast a neutral loss scan for m/z
183 reveals the presence of N-acetyl-PE lipids with great sensitivity. Analogous scans can
detect, selectively and sensitively, several common types of endogenous phospholipids
including phosphatidyl choline (PC), -ethanolamine (PE), -serine (PS), and - inositol (PI), as
shown in Figure 3 for a Folch extract of lipids from unteated control rat hepatocytes.
Collectively, these scans reveal the major types of fatty acid moieties present in the
phospholipids of rat hepatocytes.24, 25 This information provides important background for
interpreting mass spectra of xenobiotic lipid adducts as discussed below.
Lipid adducts from TASO-treated rat hepatocytes
To look for lipid adducts of TASO formed in living cells, freshly isolated rat hepatocytes
(2.2 × 107 cells in 2.2 mL medium) were incubated with [14C]-TASO (10 mM) for 4 h at 37
°C. After centrifuging the cells a Folch extract of lipids was made and found to contain 0.55
mg lipids/106cells. When examined by TLC alongside synthetic standards of 19 and 20 as
well as lipids extracted from untreated control cells, a new spot slightly more polar than
TASO appeared under staining with iodine vapor (M1 in Figure 1). The Rf of this material
was identical to that of N-acetimidoyl-DPPE but distinct from that of N-acetyl-DPPE, and it
was not formed if cells were first heated to 70 °C to inactivate the enzymes that oxidize
TASO. Phosphorimaging of the TLC plate (Figure 1), followed by scraping and counting the
radioactive zones, showed that the new spot contained 65% of the total radioactivity on the
TLC plate; traces of TASO (and also TA) were present in the extract and are barely visible
in the phosphorimage as well. The radioactivity in the new spot corresponded to a lipid
covalent binding level of 67 nmol-equiv./mg cellular lipid (i.e., 37 nmol-equiv./million
cells). Assuming that PE comprises ca. 20% of the total phospholipid extract, and that the
average PE has a MM of 760 g/mol, this corresponds to an adduct density of 0.25 (i.e., one
PE molecule in four has been adducted), which is very close to what we observed for
adduction of PE lipids by thiobenzamide metabolites.13 For comparison, the protein
covalent binding (which will be described in detail in a separate publication) corresponded
to 20 nmol-equiv./mg protein (i.e, 20 nmol-equiv./million cells).
In separate experiments rat hepatocytes were incubated with a mixture of TASO and
[13C2D3]-TASO (mole ratio M/M+5 = 10:6) and the lipids were extracted and analyzed by
MS/MS to search for precursors of m/z 183 and m/z 188 (corresponding to M and M+5
forms of (HO)2P(O)OCH2CH2NHC(=NH2 +)CH3 (viz. Figure 2A). The precursor ion scan
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for 183 (Figure 4A) shows a strong “phospholipid-like” pattern resembling some of the
scans of endogenous lipids (particularly the PEs) shown in Figure 3D. Thus the various
major mass peaks in Figure 4A all correspond to logical fatty acid side chain combinations
found among the endogenous PEs of hepatocytes, except for the addition of 41 Da for the N-
acetimidoyl group. The corresponding precursor scan for m/z 188 (Figure 4B) shows a
pattern nearly identical to that in Figure 4A except that the peaks are all shifted +5 mass
units and their intensity is only about 60% that of Figure 4A, which is as expected for the
isotope ratio built into the TASO sample used in the incubation. Comparable peaks were
completely absent from similar (m/z 183 or 188) precursor ion scans of lipids extracted from
untreated control cells (data not shown). Thus, N-acetamidine derivatives of PE lipids are
clearly formed during the metabolism of TASO by isolated hepatocytes, but are not present
in untreated control cells.
A similar search for N-acetyl-PE lipids from TASO-treated and untreated hepatocytes was
made using the appropriate neutral loss (NL) scans for m/z 183 and 188 (Figures 5A–D). In
this case, the NL183 scan (Figure 5A) shows a quasi lipid-like pattern, but the masses of the
major peaks do not agree well with the endogenous PE lipid composition indicated in
Figures 3D or 4A. This strongly suggests that the material giving rise to this spectrum is not
derived from endogenous PE lipids. A glance at the corresponding NL188 scan in Figure 5B
confirms this, because the spectrum is very weak and looks nothing like the NL183 scan in
Figure 5A (whereas the profile in Figure 4B is nearly identical to that in Figure 4A except
for the mass offset of 5u). Furthermore, the NL 183 scan of lipid extracted from untreated
hepatocytes (Figure 5C) looks almost identical to the scan of the lipid from the treated cells
(Figure 5A), suggesting that TASO treatment did not affect the materials giving rise to these
scans. This conclusion is supported by the absence of corresponding peaks in the M+5
spectra (Figure 5D) which again indicates that the materials do not contain metabolites of
the labeled TASO. The peak pattern in Figures 5A and 5C actually resemble somewhat the
peak pattern of the survey scan of the PC lipids shown in Figure 3C, and the major peak
masses indicated in Figures 5A and 5C (which have ca. 1% of the intensity of the PC scan in
Figure 3) correspond to the empirical composition [PC − H + Na]+. This would explain why
the masses do not shift after the cells are treated with dual-labeled TASO. From all of this
we conclude that N-acetyl-PE lipids are essentially absent from the lipid extract of both
untreated and TASO-treated hepatocytes. If N-acetyl-PE lipids exist in hepatocytes at all, it
is only at very low levels, and they clearly are not formed during the metabolism of TASO.
As a final comment on the amidino-lipid adducts that are formed when cells are treated with
TASO, it is clear that there is no discrimination among the endogenous PE lipids with
respect to the lengths of their fatty acyl side chains, and that no carbons or hydrogens from
TASO are incorporated into the fatty acyl chains of the PE lipids.
Reaction of TASO2 with PE lipids in vitro
To investigate the chemical reactivity of TASO2 toward PE lipids in vitro we oxidized an
aqueous solution of TASO (10 equiv.) with hydrogen peroxide (9 equiv) in the presence of
DPPE (which was present mainly as liposomes and micelles). This lead to low yields (ca.
5%) of N-acetyl-DPPE (19) but no observable N-acetimidoyl- DPPE (20) was formed.
Despite the low yield, this result is striking because during the oxidative metabolism of
TASO in vivo, only 20 is formed. Since 20 is very stable with respect to hydrolysis, the
formation of only 19 and not 20 in vitro means that TASO2 must hydrolyze completely to
generate acetylsulfinic acid (15b in Scheme 1) prior to reacting with DPPE. When the
reaction was carried out in 10% aqueous tetrahydrofuran (THF) solution the yield of 19
increased to 64%, but still no amidino adduct 20 was formed. The exclusive formation of
amidino-PE lipids (i.e. 18b in Scheme 1) in living cells must therefore reflect an
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intracellular environment in which the thermodynamic activity of water is very low
compared even to 10% aqueous THF.
Reaction of TASO2 with a model protein in vitro
To investigate the chemical reactivity of TASO2 toward proteins we oxidized TASO with
aqueous hydrogen peroxide in the presence of lysozyme as a model protein. Lysozyme has
six lysines and a free amino terminus that could potentially react with acylating agents. It
also has two methionines that could react with hydrogen peroxide, four disulfides and no
free cysteine -SH groups. In an initial experiment lysozyme (5 mg in 1 mL water) was
treated with TASO and H2O2 (1.5 and 0.75 mol per mole lysine residue, respectively) at
room temperature for 120 min (i.e., to completion of reaction). Direct analysis of the
solution by ESI mass spectrometry revealed largely unchanged lysozyme (14,305.5 ± 1 Da;
Figure 6A) plus a small new peak (ca. 5%) at M+41 or M+42 that could be either a mono
acetimidoyl adduct, a mono-acetyl adduct or a mixture of both (Figure 6B). In addition there
was a larger peak (ca. 20%) at M+16 and a much larger peak (ca. 35%) at M+96. Exposing
lysozyme to progressively larger excesses of TASO/H2O2 produced progressive increases
primarily in the peaks at M+16, M+32, M+98 and M+196 (data not shown).
The ions at M+98 and M+196 were presumed to arise as non-covalent adducts of lysozyme
with one or two molecules of sulfuric acid generated by the oxidative desulfurization of
TASO with hydrogen peroxide. The formation of such adducts under ESI conditions is well
precedented for basic proteins such as lysozyme (pI 9.3) and ribonuclease A (pI 8.64).26–28
We confirmed this by showing that simply adding Na2SO4 (5 eq./mol lysine) to lysozyme in
solution generates very strong non-covalent adduct ions at M+98 and M+196 (75% and 25%
of M, respectively; Figure 6C). For further analysis lysozyme treated with TASO/H2O2 was
subjected to tryptic digestion and the digest analyzed by LC-MS/MS. This confirmed that
the M+16 peaks in the whole molecule spectra were likely due to oxidation of Met-12 and/or
Met-105, as the respective tryptic peptides were clearly present in the digest (data not
shown). As indicated in Table 1, peptides containing acetylated lysines corresponding to all
six lysine residues were also present (see Supporting Information). We also observed a bis-
acetylated derivative of the peptide KVFGR corresponding the N-terminal five residues of
lysozyme. However, we observed no evidence for peptides bearing acetimidoyl adducts,
which are clearly distinguished from acetyl peptides in both MS1 and MS2 modes (see
Supporting Information).
It is of course conceivable that the observed acetyl modifications resulted from the
hydrolysis of an acetimidoyl precursor (see Scheme 2, structures 16 and 17). To rule this out
we prepared acetimidoylated lysozyme using only a slight excess of methyl acetimidate
hydrochloride. As shown in Figure 6D, methyl acetimidate very efficiently modifies
lysozyme, producing a series of species containing up to seven adducts of 41 u each. This
would suggest that MA is capable of modifying all six lysines plus the N-terminal amine
group of lysozyme. Tryptic digestion and LC-MS/MS analysis of a sample of lysozyme
treated with 1.5 mol MA per mol lysine side chain showed that all six lysines were capable
of being adducted. We observed only a mono-acetimidoyl adduct of the N-terminal peptide
KVFGR; it eluted as a single peak on the chromatogram, but it was not clear from the CID
spectrum if it arose from modification of the lysine side chain or the amino terminus.
Importantly, however, no acetylated peptides were observed in reactions with methyl
acetimidate, indicating that the amidino modification was stable to handling (including
tryptic digestion) and was not a precursor to the acetyl adducts formed via treatment with
TASO/H2O2. For comparison in regard to efficiency as a protein lysine modifying reagent,
lysozyme was also treated with up to 50 equivalents of acetic anhydride per lysine residue
and then submitted to whole molecule mass spectrometry (Figure 6E) as well as tryptic
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digestion and LC-MS/MS. Even when added at this great molar excess, acetic anhydride
was not as efficient as MA at modifying lysine residues in lysozyme (Table 1). However, all
six lysines and the N-terminal amino group were observed to be acetylated in the digest, and
for both modifications there was a preference for the K97 over the adjacent K96 in
lysozyme.
Discussion
Thioacetamide is an interesting if not unusual hepatotoxin. It is a small, polar, water soluble
molecule yet it is capable of causing a variety of noxious biological effects depending on the
dose and duration of its administration. Rats fed with TA at 0.025% of their diet for 6
months exhibit decreased growth rates, decreased survival time and prominent cirrhotic
changes in their liver.29 At 0.1% of the diet survival is less than one month, the livers show
bile duct proliferation and the hepatocytes show grossly enlarged nucleoli. Rats given TA in
their drinking water (0.03%) for 20 weeks exhibit changes that progress from biliary
hyperplasia to cholangiocarcinoma in a way that models the human disease progression 30
Rees et al.31 investigated the disposition and metabolism of [3H]-TA in rats and observed
that less than 1% of the dose was excreted unchanged, while >90% was converted to acetic
acid and entered the acetate pool. At the same time tritium was incorporated into proteins >
phospholipids > nucleic acid. Liver and kidney slices converted TA into acetamide and
radiolabeled phospholipids. From this it was concluded that TA was desulfurized to
acetamide, hydrolzed to acetate and biosynthetically incorporated into fatty acids for
phospholipid synthesis. However, the results of our lipid analysis by mass spectrometry
clearly show that the acyl moiety derived trom [13C2D3]-TA is adducted onto the head
group of PE lipids and is not incorporated into their fatty acyl chains.
Dyroff and Neal14, 15 characterized the covalent binding of [14C]-TA to liver proteins of
rats, and to BSA when incubated with rat liver microsomes and 18OH2. Enzymatic digestion
of the proteins released [14C]-ε-acetyllysine, and GC/MS analysis of the latter showed that
the oxygen atom of the acetyl group originated from water and not molecular oxygen. Since
amidines are not easily hydrolyzed to amides,13, 15 the reactive metabolite of TA (i.e.,
TASO2, 11b/12b in Scheme 2) must react first with water to form a new reactive metabolite,
acetylsulfinic acid (15b), which then acylates lysine side chains. The requirement for two
stages of two-electron oxidation to produce a reactive metabolite from a thioamide group is
unusual among metabolically activated toxins, but it is even more unusual that a reactive
metabolite would react with water to form a new compound that retains a high degree of
spontaneous chemical reactivity toward biological nucleophiles.
In subsequent studies of the covalent binding of thiobenzamide metabolites in rat liver we
were surprised to observe extensive modification of cellular lipids as well as proteins. We
identified 65 different target proteins and observed numerous adducts on ε-amino groups of
lysine residues in peptide digests. The adducts included both N-benzoyl and N-benzimidoyl
groups in the ratio of ca. 3:1 12. In contrast the microsomal lipid adducts consisted
exclusively of N-benzimidoyl derivatives of PE lipids 13. In the present study we observed
analogous results from hepatocytes incubated with thioacetamide, i.e., modified lipids
contained only N-acetimidoyl- PE derivatives whereas the proteins contained both amide
and amidine adducts (unpublished results, manuscript in preparation). To investigate this
discrepancy further we performed chemical oxidations of TASO in the presence of model
lipids and proteins and analyzed the products by mass spectrometry.
The oxidation of TASO with hydrogen peroxide in the presence of DPPE under aqueous
conditions where liposomes and micelles are present resulted in a low yield of modified
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DPPE containing only amide adducts. Using a larger excess of TASO/HOOH or a higher
reaction temperature improved the yield modestly but again only amide adducts were
formed. This suggests that in the presence of water as a solvent, both the hydrolysis of
TASO2 to 15b and the hydrolysis of 15b to acetic acid are faster than the reaction of TASO2
with DPPE. Since most biological systems are only 60% water, we carried out the same
reaction in THF containing only 10% water to see if that would favor amidine formation.
Reducing the water content significantly improved the overall yield of adduct, but again
only the amide adduct was formed.
The exclusive formation of amidine-type DPPE adducts in TASO-treated hepatocytes and
TB-treated rats implies that upon enzymatic formation and release in living cells, the
reactive metabolite (i.e., 11 or its tautomer 12 does not have sufficient time, or does not
encounter sufficient local water, to hydrolyze to 16 before reacting with the amine groups of
PE lipids. This does not appear to be the case for proteins, however, as with both TB12 and
TA (unpublished results, manuscript in preparation), three-fourths of the lysine adducts
formed in cells are amides. The enzymes that oxidize thioamides (i.e., FMO and/or
cytochromes P450) are both located in the endoplasmic reticulum, a membranous structure
that occupies 15% of the cell volume. The ER membrane consists of ca. 70% protein and
30% lipids with PCs (55%) and PEs (20–25%) predominating. Its lumen also contains
numerous soluble proteins, some of which are targets for reactive metabolites including
those of TB and TA.32 Clearly the behavior of thioamide-derived reactive metabolites in the
interior of a living cell is not well modeled by their behavior in aqueous solution.
The toxicity of compounds that generate electrophilic metabolites is usually associated with
the covalent binding of the metabolites to cellular macromolecules. Those that covalently
modify DNA are often mutagenic or even carcinogenic, while those that covalently modify
proteins are often associated with cytotoxic effects. Lipids are not usually thought of as
targets for electrophilic metabolites, although several precedents involving the amine group
of PE phospholipids exist. For example phosgene, formed by oxidative metabolism of
chloroform,33 forms lipid adducts by crosslinking two molecules of PE through their amine
groups in a urea linkage. Similarly the oxidative metabolite of halothane trifluoroacetylates
the amine group of PE lipids34, while the reactive metabolite generated by the action of
cysteine conjugate β-lyase on S-(1,1,2,2-tetrafluoroethyl)-L-cysteine generates
difluorothioacetyl-PE adducts35 and, as noted above, the S,S-dioxide metabolite of
thiobenzamide benzimidoylates the amine group of PE lipids in microsomal membranes.12
While lipids are not well known as targets of reactive electrophiles, they are well known as
precursors of reactive electrophiles including malondialdehyde, 4-hydroxynonenal, 4-
oxononenal and related γ-ketoaldehydes formed from PGH2 or certain autoxidized
arachidonyl esters (i.e., levuglandins or isoprostanes, respectively).36 These lipid-derived
species are quite reactive toward biological nucleophiles including the amine group of
proteins and PE lipids, with which they react to form N-substituted pyrroles.18, 37, 38
Interestingly, the pyrrolic adducts isoprostane-derived isoketals have been shown to be
directly cytotoxic in HEK293 cells and human umbilical vein endothelial cells.38
Long-chain N-acyl PEs occur naturally in bacteria, yeast, plants and vertebrates from fish to
mammals.18 Their concentration is low in human tissues (<0.1% of phoshphlipids)39 and
plasma (20–200 nM).40 They are synthesized in response to stresses such as ischemia,
dehydration and glutamate-induced excitotoxicity.17, 19, 40 They also serve as precursors of
N-acylethanolamines including anandamide, the endogenous ligand for the cannabinoid
receptor, via phospholipase D hydrolysis.16, 17, 40, 41 N-Acylation converts a PE from a
zwitterionic lipid to an anionic lipid altering intramolecular hydrogen bonding and
conformation around the head group. If the acyl chain is longer than about C8 it can bend
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around and insert into the bilayer raising its chain melting temperature.41 N-Acetyl PEs are
good substrates for phospholipase A2 but as the N-acyl chain lengthens to C16 the rate of
hydrolysis falls to zero. It has not been determined if N-acetyl-, N-acetimidoyl, N-benzoyl-
or N-benzimidoyl PE lipids can be hydrolyzed by phospholipase D, nor is anything known
about the overall clearance of such metabolites from the cell or organism, or their potential
for exerting toxic effects. This area is prime for investigation using cultured cells, stable
isotopes and mass spectrometry.
Although the existence of N-terminal acetylation as a post-translational modification of
cellular proteins has long been known, mass spectrometry has recently revealed that a
plethora of proteins undergo reversible N-acetylation at internal positions (i.e. the
“acetylome”), and that these PTMs have important consequences for protein function in
diverse cellular processes including the cell cycle.42 Given that a hepatotoxic dose of TA
leads to extensive protein acetylation (as well as acetimidoylation) it is not difficult to
imagine that this could interfere with endogenous signaling and regulatory mechanisms in a
way that would compromise the cell.
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TLC analysis of lipid standards and lipid extract from TASO-treated hepatocytes. Lane 1,
standards of N-acetyl-DPPE (S3, Rf = 0.48), N-acetimidoyl-DPPE (S2, Rf = 0.37) and
DPPE (S1, Rf = 0.20); solvent = CHCl3/MeOH/NH4OH, 80:20:3 v/v. Lane 2, lipid extract
of hepatocytes after incubating 4 h with [14C]-TASO. Lane 3, phosphorimage of lane 2.
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ESI mass spectra of A) N-acetimidoyl-DPPE and B) N-acetyl-DPPE standards showing the
relevant fragmentation. For the more basic amidine the charge is carried by the head group
derived fragment (m/z 183), while for the less basic amide the charge is carried by the
diacylglycerol-derived fragment (m/z 551).
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Class-specific phospholipid survey scans applied to a lipid extract of untreated hepatocytes.
A) Neutral loss of 277 scan for phopshatidylinositols. B) Neutral loss of 185 scan for
phosphatidylserines. C) Scan for precursors of 184 for phosphatidylcholines. D) Neutral loss
of 141 scan for phosphatidylethanolamines. Insets show the respective polar group involved
in the diagnostic fragmentation. Major peaks are labeled by m/z and the total number of
carbons and double bonds in the two acyl sidchains. In all cases, 38:4 is the major
diacylglycerol moiety.
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Survey scans for N-acetimidoyl PE lipids in lipid extract of hepatocytes treated with a
mixture of TASO and [13C2D3]-TASO (10:6 mole ratio). Panel A, precursors of m/z 183.
Panel B, precursors of m/z 188. Major peaks are labeled by m/z and the total number of
carbons and double bonds in the two acyl sidchains.
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Survey scans for N-acetyl PE lipids in lipid extract of hepatocytes treated with a mixture of
TASO and [13C2D3]-TASO (10:6 mole ratio). Panel A, neutral loss of m/z 183. Panel B,
neutral loss of m/z 188. Panels C and D are analogous scans made from lipid extract of
untreated hepatocytes. Major peaks are labeled by m/z and the total number of carbons and
double bonds in the two acyl sidchains. See text for discussion.
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ESI mass spectra of lysozyme, either unreated (A), or treated with with 9 equiv. TASO/
HOOH (B), 30 equiv. sodium sulfate (C), 9 equiv. methyl acetimidate (D), or 300 equiv.
acetic anhydride (E). All samples were prepared in deionized water.
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Representative structures of biologically active thioarbonyl compounds.
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Bioactivation of thioamide derivatives.
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Structures of modified DPPE standards.
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Table 1
Modification of lysine residues on lysozyme by acylating reagents.
Reagent (mol/mol lysine) Adductiona Observed Modificationsb
TASO/H2O2 (1.5/0.75) <0.05 All lysines, amides only
methyl acetimidate (1.5) 2.8 All lysines, amidines only
acetic anhydride (50) 2.1 All lysines, amides only
a
Weighted average of number of adducts per molecule of protein by whole molecule MS.
b
Modifications observed by LC-MS/MS analysis of tryptic digest. See Supporting Information.
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